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Abstract Evidence is presented showing that in a patient with
fatal neurological syndrome, the homozygous 5 bp duplication in
the cDNA of the NDUFS4 18 kDa subunit of complex I
abolishes cAMP-dependent phosphorylation of this protein and
activation of the complex. These findings show for the first time
that human complex I is regulated via phosphorylation of the
subunit encoded by the NDUFS4 gene. ß 2001 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
In mammals complex I of the respiratory chain is made up
of 43 subunits [1,2]. Seven subunits (ND1^ND6, ND4L) are
encoded by the mitochondrial genome [3], the others by nu-
clear genes [1,4]. The cDNAs of 35 of the human nuclear
genes coding for complex I subunits have been sequenced
[5], but for most of them the function is unknown [5,6].
Papa et al. [7,8] have found that in bovine heart mitochondria
the nuclear encoded 18 kDa subunit of complex I is phosphor-
ylated by cAMP-dependent protein kinase. The mature 18
kDa protein, which does not bind prosthetic groups, has, in
Bos taurus at position 129^131, a canonical cAMP-dependent
protein kinase phosphorylation consensus site (RVS) in which
S is the residue that is phosphorylated (Fig. 1) [9,10]. The
protein has a leader sequence, removed after import in mito-
chondria [11], that also presents a phosphorylation consensus
site (RSLS) at position 310^37. The 18 kDa subunit of com-
plex I appears to be highly conserved in the known sequences
of mammals [11^13]. Further investigations [9,14] showed
cAMP-dependent phosphorylation of the 18 kDa subunit
and activation of complex I in mouse ¢broblasts in vivo.
Subsequently, van den Heuvel et al. [12] sequenced the
cDNA of the NDUFS4 gene, encoding the 18 kDa subunit, in
patients with complex I de¢ciency. In a child, with fatal neu-
rological Leigh-like syndrome, they detected a homozygous
5 bp duplication in the cDNA of the 18 kDa subunit, resulting
in destruction of the phosphorylation site. The mutation was
transmitted by autosomal recessive mode of inheritance [12].
In skin ¢broblasts from this patient we have now found that
cAMP fails to promote phosphorylation of the 18 kDa sub-
unit of complex I and to activate the complex. These ¢ndings
show for the ¢rst time that human complex I is regulated via
phosphorylation of the subunit encoded by the NDUFS4
gene.
2. Materials and methods
2.1. Materials
DMEM, PBS, trypsin (0.05%), EDTA (0.02%), penicillin, strepto-
mycin, calf serum and fetal bovine serum were from EuroClone;
decylubiquinone, IBMX, antimycin-A, rotenone, CCCP, protein-A
Sepharose and mouse monoclonal antibody against phosphoserine
from Sigma. Horseradish peroxidase conjugate goat anti-mouse IgG
antibody, dodecylmaltoside, high-purity digitonin, okadaic acid and
cholera toxin were from Calbiochem. ECL system from NEN Life
Science. Hyper¢lm-MP from Amersham International. Nitrocellulose
membrane from Schleicher and Schuell.
2.2. Case report
Male patient (from a collection of complex I de¢cient patients from
the Nijmegen Medical Center) born after normal pregnancy as the
second child of healthy non-consaguineous parents. Hospitalized at
the age of 8 months was diagnosed as a Leigh-like neurological syn-
drome [12]. The child died of cardiorespiratory failure at the age of
16 months. The patient exhibited normal values for routine clinical
chemical blood and urine analyses. Lactic acid concentration in blood
and cerebrospinal £uid were normal. Enzymatic analyses of a skeletal
muscle biopsy and skin ¢broblast cultures revealed a decreased activ-
ity of complex I and a slightly reduced complex III activity in both
tissues [12].
2.3. Fibroblast cell culture
Skin human ¢broblasts, stored in liquid nitrogen, were grown in
high glucose DMEM supplemented with 10% fetal bovine serum at
37‡C till 75% con£uence. This medium was then replaced with
DMEM supplemented with 0.5% fetal bovine serum. After 3 days
of serum starvation the cells were treated for 3 h with 1 Wg/ml cholera
toxin+100 WM IBMX, an inhibitor of cAMP phosphodiesterase. This
treatment induces massive intracellular cAMP production [15]. The
cells were harvested from Petri dishes with 0.05% trypsin, 0.02%
EDTA, and phosphatase inhibitors (5 mM NaF, 500 nM okadaic
acid, and 1 mM sodium orthovanadate). After addition of 50 ml of
PBS, pH 7.4 with 5% calf serum, cells were collected by centrifugation
at 500Ug.
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2.4. Mitoplast preparation
For mitoplast preparation freshly harvested human ¢broblasts, sus-
pended in PBS, were exposed for 10 min on ice to 0.2 mg of digitonin/
mg cellular protein. The mitoplast fraction was pelleted by centrifu-
gation of the suspension at 14 000Ug for 10 min.
2.5. Electrophoresis and immunoblotting
Two-dimensional gel analysis (blue-native PAGE/SDS^PAGE) of
the mitoplast fraction from human ¢broblasts was performed as de-
scribed in [14,16]. Mitoplast immunoprecipitation with a polyclonal
antibody against the 75 kDa subunit of complex I, SDS^PAGE of the
immunoprecipitate and immunoblotting with monoclonal anti-phos-
phoserine antibody and polyclonal antibody against the 24 kDa sub-
unit of complex I were carried out as described previously [14]. Den-
sitometric scanning of immunoblots was performed with a CAMAG
TLC Scanner II and a D2500 Cromato intergrator, Merck Hitachi.
2.6. Cellular respiration
Human ¢broblasts were suspended in PBS, and respiration was
monitored by oxygen polarography.
2.7. Measurement of enzymatic activities
For measurements of the NADH:Q oxidoreductase activity, serum-
starved ¢broblasts were exposed to ultrasound energy for 15 s at 0‡C
to eliminate permeability barriers for exogenous NADH and decyl-
ubiquinone. The NADH:Q oxidoreductase activity of cells (5U105
cells) was determined at 25‡C in 700 Wl of 40 mM potassium phos-
phate bu¡er (pH 7.4), 5 mM MgCl2 and 3 mM KCN with NADH as
reductant and 200 WM decylubiquinone as oxidant following spectro-
photometrically the oxidation of 1.25^25 WM NADH at 360^374 nm,
vO 2.01 mM31 [14]. At each concentration of NADH the activity was
measured in the absence (a) and presence of 1 Wg/ml rotenone (b). The
rotenone-sensitive NADH:Q oxidoreductase was the di¡erence, a3b.
Cytochrome c oxidase activity was determined as described in [17].
3. Results
Skin ¢broblasts from the patient were cultivated under se-
rum starvation for 3 days, which results in down-regulation of
the cAMP-dependent phosphorylation and activity of com-
plex I [14]. Fibroblasts were then treated for 3 h with cholera
toxin, which induces massive intracellular cAMP production
[15] and, under normal conditions, consequent activation of
complex I [14]. Complex I, separated by blue-native PAGE of
Fig. 1. Sequence alignment of the 18 kDa subunit of mouse, human and bovine complex I. Sequences were obtained from the Swiss protein da-
tabase (see also [1,11^13]). The residue numbering refers to the mature mouse, human and bovine proteins. Invariant and homologous residues
are shaded in gray. Canonical phosphorylation consensus sites for cAMP-dependent protein kinase are shaded in black.
Table 1
E¡ect of cholera toxin on enzymatic and respiratory activities of control and patient’s serum-starved ¢broblasts
Control ¢broblasts Patient’s ¢broblasts
Serum-starved +Cholera toxin Serum-starved +Cholera toxin
Vmax Km Vmax Km Vmax Km Vmax Km
fmol/min/cell WM NADH fmol/min/cell WM NADH fmol/min/cell WM NADH fmol/min/cell WM NADH
A. Enzymatic activities
NADH:Q oxido-
reductase
2.39 þ 0.15(8) 2.77 þ 0.40(8) 6.46 þ 0.37(8) 6.51 þ 1.13(8) 1.86 þ 0.35(5) 4.8 þ 3.08(5) 2.14 þ 0.47(5) 5.0 þ 2.4(5)
P6 0.001 N.S. N.S. N.S.
fmol/min/cell fmol/min/cell fmol/min/cell fmol/min/cell
Cytochrome c oxidase 9.87 þ 5.08(3) 13.53 þ 3.30(3) 19.76 þ 3.38(3) 19.91 þ 6.29(3)
N.S. N.S.
femtoatoms O/min/cell femtoatoms O/min/cell femtoatoms O/min/cell femtoatoms O/min/cell
B. Substrates
Glutamate+malate 3.38 12.23 4.29 5.49
Ascorbate+TMPD 6.40 5.88 5.83 7.95
Serum-starved human ¢broblasts, from control and patient, and starved ¢broblasts incubated, where indicated, 3 h with cholera toxin+IBMX,
were suspended in phosphate-bu¡ered saline with phosphatase inhibitors and immediately respiration and enzymatic activities were determined
as described in Section 2 [14]. Vmax and Km were obtained from Lineweaver^Burk plots of the rotenone-sensitive NADH^ubiquinone oxidore-
ductase. Respiration was measured polarographically on ¢broblast suspension (1.5^2U106 cells) in 650 Wl of 75 mM sucrose, 30 mM Tris^Cl,
50 mM KCl, 0.5 mM EDTA, 0.5 mM MgCl2, 2 mM potassium phosphate bu¡er, pH 7.4, 1 WM CCCP (carbonyl-cyanide-m-chlorophenylhy-
drazone). Cells were permeabilized with 0.002% digitonin. Substrate concentrations were: 10 mM glutamate, 10 mM malate, 2 mM ascorbate
and 0.2 mM TMPD (N,N,NP,NP-tetramethyl-p-phenylenediamine). Complex I Vmax and Km and cytochrome oxidase activity values represent
means þ S.E.M., with number of experiments in parentheses. The respiratory activities are the means of two measurements on di¡erent batches
of ¢broblasts.
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the mitoplast fractions obtained from control and patient’s
¢broblasts, was resolved into constituent subunits by two-di-
mensional SDS^PAGE. The immunoblots with an antibody
against phosphoserine, presented in Fig. 2A, show that the
exposure of control ¢broblasts to cholera toxin promoted ser-
ine phosphorylation in the 18 kDa subunit of complex I. In
the patient’s ¢broblasts the same treatment did not result in
phosphorylation of this subunit. In control ¢broblasts promo-
tion by cholera toxin treatment of serine phosphorylation in
the 18 kDa subunit of complex I was also evident in the
mitoplast fraction immunoprecipitated by a polyclonal anti-
body against the 75 kDa subunit of complex I (Fig. 2B). Fail-
ure of the cholera toxin treatment to promote phosphoryla-
tion of the 18 kDa subunit in the patient was con¢rmed in the
immunoprecipitate of complex I.
It can be noted that the content of the 24 kDa subunit of
complex I was in the patient’s ¢broblasts the same as in con-
trol ¢broblasts (Fig. 2B,C). This indicates that the present
mutation in the NDUFS4 did not impair assembly of complex
I in mitochondria.
Table 1 summarizes data on the Vmax and Km values, ob-
tained from typical Lineweaver^Burk plots, of the normal
rotenone-sensitive NADH^ubiquinone oxidoreductase in con-
trol and patient’s serum-starved ¢broblasts, previously ex-
posed to ultrasonic energy to eliminate permeability barriers
for exogenous NADH and decylubiquinone. It can be seen
that in serum-starved conditions, there was only small di¡er-
ence in the Vmax of the rotenone-sensitive NADH^ubiquinone
oxidoreductase activity in the patient’s ¢broblasts as com-
pared to control ¢broblasts. The cholera toxin treatment,
which increased by more than two-fold the Vmax of the rote-
none-sensitive NADH^ubiquinone oxidoreductase activity in
control ¢broblasts, failed to produce activation of the activity
of complex I in patient’s ¢broblasts. In both control and
patient’s ¢broblasts cholera toxin treatment had no statistical-
ly signi¢cant e¡ect on the Km of NADH^ubiquinone oxido-
reductase activity. It was also noted that the patient’s ¢bro-
blasts showed enhancement of a rotenone-insensitive NADH^
ubiquinone oxidoreductase activity, which was una¡ected by
cholera toxin treatment. The nature of this activity remains to
be clari¢ed. In control serum-starved ¢broblasts the cholera
toxin treatment enhanced by more than three-fold the overall
respiration supported by NAD-linked substrate, but failed to
exert signi¢cant e¡ect on respiration in serum-starved pa-
tient’s ¢broblasts (Table 1). Cytochrome c oxidase (complex
IV) was not depressed in the patient’s ¢broblasts as compared
to control ¢broblasts. Both in control and in patient’s ¢bro-
blasts cholera toxin treatment had no signi¢cant e¡ect on this
activity (Table 1).
4. Discussion
The observations presented allow to draw a number of
conclusions. In the patient the 5 bp duplication in the
NDUFS4 gene, which destroys the phosphorylation site in
the 18 kDa subunit of complex I [12], abolishes cAMP-depen-
dent phosphorylation of the 18 kDa mitoplast protein band
attributed to complex I and activation of the normal rote-
none-sensitive NADH^ubiquinone oxidoreductase activity of
the complex in ¢broblast cultures. Independent controls
showed that the NDUFS4 protein was present in the ¢bro-
blasts of the patient. Whilst the present work was being com-
pleted three new mutations in the NDUFS4 gene were found
in patients with complex I de¢ciencies. All these mutations
resulted in destruction of the consensus phosphorylation site
in the C-terminus of the NDUFS4 protein ([18] and V. Pe-
truzzella, R. Vergari, I. Puzziferri, D. Bo¡oli, E. Lamantea,
M. Zeviani and S. Papa, manuscript in preparation). These
¢ndings provide substantial evidence showing that cAMP-
mediated intracellular signal transduction, through serine
phosphorylation of the NDUFS4 18 kDa subunit of complex
I regulates the activity of the complex in cAMP-responsive
mammalian tissues. Since complex I represents, at least under
Fig. 2. Immunodetection of phosphoserine-containing proteins in
human ¢broblasts. A: Western blot of SDS^PAGE of complex I,
separated by blue-native PAGE of mitoplasts [16] from serum-
starved human ¢broblasts, immunodecorated with anti-phosphoser-
ine antibody. Mitoplasts (10, 20, 30 Wg proteins) from control ¢bro-
blasts (a), control ¢broblasts treated with cholera toxin (b), patient’s
¢broblasts (c), patient’s ¢broblasts treated with cholera toxin (d),
were applied to a 5^13% blue-native gradient gel. Complex I band
was cut from the gel and runned in a two-dimensional SDS^PAGE,
blotted onto nitrocellulose, incubated with mouse anti-phosphoserine
antibody and developed using ECL system. B: Western blot of mi-
toplasts fraction immunoprecipitated with a polyclonal antibody
against the 75 kDa subunit of complex I. Mitoplasts from ¢bro-
blasts were solubilized in 1% laurylmaltoside and incubated over-
night with the antibody against the 75 kDa subunit of complex I,
preadsorbed on protein-A activated Sepharose. The immunoprecipi-
tate was dissolved in lysis bu¡er, resolved by SDS^PAGE, blotted
onto nitrocellulose, immunodecorated with mouse anti-phosphoser-
ine and rabbit anti-24 kDa subunit of complex I antibodies and de-
veloped using ECL system. C: Densitograms of the 24 kDa subunit
immunoblots.
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certain conditions, the rate-limiting step of the mitochondrial
respiratory chain, up-regulation of complex I by cAMP-in-
duced phosphorylation of the NDUFS4 18 kDa subunit can
activate the overall cellular respiratory activity and aerobic
ATP production.
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